A Pilot Study of Intelligent Control of Nanorobots using AI & ML

Recent advancements in artificial intelligence (AI) and nanotechnology have enabled the development of intelligent nanorobots, offering a transformative approach to disease management, particularly in the fields of neuro pharmaceutics and blood disease monitoring. This Study explores the potential of nanoparticles in biomedical engineering, specifically focusing on their application as nanorobots capable of crossing the blood-brain barrier (BBB) for targeted payload delivery in brain tumors and neurological disorders such as Alzheimer's and Parkinson's diseases. These nanorobots, designed with sensors, actuators, power sources, and communication systems, utilize AI algorithms for precise navigation within the bloodstream. Materials like graphene and gold nanoparticles ensure biocompatibility, enhancing both safety and efficacy in delivering targeted therapies. Furthermore, AI-driven nanorobots are revolutionizing cancer drug delivery, reducing toxicity, and improving therapeutic outcomes. Additionally, they show promise in cardiovascular health monitoring for early disease detection. However, challenges such as regulatory and technological barriers persist, necessitating ongoing research to realize the full potential of AI-powered nanorobots in personalized and precision medicine.